ESR1 and breast carcinoma: Our data suggests that AR partners with GATA3 to regulate luminal epithelial cell differentiation from early stages, represented by AR+ER- breast cancer cell lines, through to more mature stages, represented by AR+ER+ breast cancer cell lines, explaining why AR is such a prevalent sex hormone receptor in this disease.